References
- Nouri-MahdaviKHoffmanDColemanALAdvanced Glaucoma Intervention StudyPredictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention StudyOphthalmology20041111627163515350314
- BengtssonBLeskeMCHymanLHeijlAEarly Manifest Glaucoma Trial GroupFluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trialOphthalmology200711420520917097736
- HeijlALeskeMCBengtssonBHymanLBengtssonBHusseinMEarly Manifest Glaucoma Trial GroupReduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma TrialArch Ophthalmol20021201268127912365904
- GordonMOBeiserJABrandtJDThe Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucomaArch Ophthalmol200212071472012049575
- SherwoodMBCravenERChouCDuBinerHBBatoosinghALSchiffmanRMWhitcupSMTwice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trialArch Ophthalmol20061241230123816966616
- GoñiFJBrimonidine/Timolol Fixed Combination Study Group12-week study comparing the fixed combination of brimonidine and timolol with concomitant use of the individual components in patients with glaucoma and ocular hypertensionEur J Ophthalmol20051558159016167288
- CravenERWaltersTRWilliamsRChouCCheethamJKSchiffmanRCombigan Study GroupBrimonidine and timolol fixed-combination therapy versus monotherapy: a 3-month randomized trial in patients with glaucoma or ocular hypertensionJ Ocul Pharmacol Ther20052133734816117698
- KonstasAGKatsimprisIEKaltsosKTwenty-four-hour efficacy of the brimonidine/timolol fixed combination versus therapy with the unfixed componentsEye2008221391139717571086
- ArcieriESArcieriRSPereiraACAndreoEGFinottiIGSá FilhoWFComparing the fixed combination brimonidine-timolol versus fixed combination dorzolamide-timolol in patients with elevated intraocular pressureCurr Med Res Opin20072368368917407624
- FramptonJETopical brimonidine 0.2%/timolol 0.5% ophthalmic solution: in glaucoma and ocular hypertensionDrugs Aging20062375376117020399
- AlvaradoJAReduced ocular allergy with fixed-combination 0.2% brimonidine-0.5% timololArch Ophthalmol200712571717502523